buserelin has been researched along with Polycystic Ovarian Syndrome in 87 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 23 (26.44) | 18.7374 |
1990's | 48 (55.17) | 18.2507 |
2000's | 10 (11.49) | 29.6817 |
2010's | 6 (6.90) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ataie, M; Haghollahi, F; Nasiri, R; Rashidi, B; Tehraninejad, ES | 1 |
Aleyasin, A; Hosseini, MA; Mahdavi, A; Saeedi, H | 1 |
Asada, Y; Endo, T; Hashiba, Y; Honnma, H | 1 |
Ciampaglia, W; Cognigni, GE; Fanelli, F; Gambineri, A; Pagotto, U; Pasquali, R; Patton, L; Prontera, O | 1 |
Aydiner, F; Dogan, S; Dogan, SS; Gulekli, B; Kovali, M | 1 |
Bonora, E; Castello, R; Dorizzi, R; Moghetti, P; Negri, C; Perrone, F; Tosi, F | 1 |
Campbell, S; Järvelä, IY; Kelly, S; Nargund, G; Ojha, K; Sladkevicius, P | 1 |
Abyholm, T; Dale, PO; Fedorcsák, P; Storeng, R; Tanbo, T | 2 |
Atmaca, H; Baybuga, H; Bayram, F; Kelestimur, F; Sahin, Y; Unluhizarci, K | 1 |
Cognigni, GE; Gambineri, A; Pasquali, R; Patton, L; Pocognoli, P | 1 |
Ozturk, O; Ranierri, M; Sahu, B; Serhal, P | 1 |
de Jong, FH; Fauser, BC; Hop, WC; Schoot, DC; van Dessel, TJ | 1 |
Bertoli, A; Di Daniele, N; Fusco, A; Gatti, S; Lauro, R; Magnani, A; Marini, MA | 1 |
Donaldson, A; Franks, S; Leigh, A; White, D; Wilson, C | 1 |
Hayashi, M; Horinaka, T; Ohkura, T; Segawa, Y; Watabe, H; Yaoi, Y | 1 |
Gersak, K; Meden-Vrtovec, H; Tomazevic, T | 1 |
Caruso, A; Fulghesu, AM; Guida, C; Guido, M; Lanzone, A; Mancuso, S; Nicoletti, MC; Villa, P | 1 |
de Jong, FH; Donderwinkel, PF; Fauser, BC; Hop, WC; Pache, TD; Schoot, DC | 1 |
Franks, S; Gilling-Smith, C | 1 |
Hompes, PG; Scheele, F; Schoemaker, J; Schoute, E; van der Meer, M | 3 |
Caruso, A; Fortini, A; Fulghesu, AM; Guido, M; Lanzone, A; Mancuso, S | 1 |
Balen, AH; Jacobs, HS; MacDougall, J; Tan, SL | 1 |
Keleştimur, F; Sahin, Y | 3 |
Cédrin, I; Lemay, A; Méchain, C; Pandian, C | 1 |
Lieberman, BA; Matson, PL; Troup, SA; Wada, I | 1 |
Bontis, J; Grimbizis, G; Lagos, S; Mantalenakis, S; Pournaropoulos, F; Spanos, E; Tarlatzis, BC | 1 |
Diaferia, A; Loizzi, P; Nicastri, PL; Tartagni, M | 1 |
Andronis, CK; Chlouverakis, CS; Devetzaki, OA; Hatziioanidis, AH; Kounadi, TG; Misichronis, GS; Piaditis, GP; Rangou, DB; Trovas, GP | 1 |
Barri, PN; Calderon, G; Coroleu, B; Martinez, F; Traver, JM; Veiga, A | 1 |
Ayata, D; Keleştimur, F; Sahin, Y | 1 |
Fridström, M; Hillensjö, T; Pousette, A; Sjöblom, P | 1 |
Agrawal, R; Bekir, J; Campbell, S; Engmann, L; Sladkevicius, P; Tan, SL | 1 |
Bayram, F; Keleştimur, F; Sahin, Y; Tutuş, A; Unlühizarci, K | 1 |
Buckett, WM; Tan, SL | 1 |
Caputo, M; Castello, R; Moghetti, P; Muggeo, M; Negri, C; Perrone, F; Tosi, F; Zanolin, E | 1 |
Ben-Shlomo, A; Hagag, P; Herzianu, I; Weiss, M | 1 |
Harada, T; Ito, M; Iwabe, T; Ohata, Y; Terakawa, N; Yoshida, S | 1 |
Al-Hasani, S; Bauer, O; El-Sheikh, MM; El-Sheikh, R; Fouad, S; Hussein, M | 1 |
Matsuyama, A; Minaguchi, H; Shirasu, K; Uemura, T; Yanagisawa, T | 1 |
Caruso, A; Fulghesu, AM; Guida, C; Lanzone, A; Le Donne, M; Mancuso, S; Nicoletti, MC; Rossi, P | 1 |
Bernardus, RE; Hompes, PG; Scheele, F; Schoemaker, J | 1 |
Abyholm, T; Dale, PO; Djøseland, O; Jervell, J; Tanbo, T | 1 |
de Jong, FH; Fauser, BC; Hop, WC; Pache, TD; Schoot, DC | 1 |
Chrisp, P; Goa, KL | 1 |
Alnaser, HM; Gadir, AA; Mowafi, RS; Shaw, RW | 1 |
Abyholm, T; Dale, PO; Tanbo, T | 1 |
Emperaire, JC; Ruffie, A | 1 |
Balint-Perić, L; Nesić, JS; Prelević, GM; Wurzburger, MI | 1 |
Johnson, P; Pearce, JM | 1 |
Andreani, CL; Apa, R; Caruso, A; Fortini, A; Fulghesu, AM; Lanzone, A; Mancuso, S | 1 |
Black, WP; Conaghan, C; Coutts, JR; Fleming, R; Hamilton, MP | 1 |
Abyholm, T; Dale, PO; Haug, E; Kjekshus, E; Tanbo, T | 1 |
Andreani, CL; Caruso, A; Fulghesu, AM; Lanzone, A; Le Donne, M; Mancuso, S; Muscatello, R; Pappalardo, S; Proto, C | 1 |
Balint-Peric, L; Prelević, GM; Würzburger, MI | 1 |
Ben-Rafael, Z; Bider, D; Blankstein, J; Kokia, E; Lipitz, S; Mashiach, S; Serr, DM | 1 |
Conaglen, JV; Gordon, P; Lowy, C; Macleod, AF; Sönksen, PH; Wheeler, MJ | 1 |
Alnaser, HM; Alzaid, HG; Gadir, AA; Khatim, MS; Mowafi, RS; Shaw, RW | 1 |
Ito, T; Kobayashi, M; Kuramoto, T; Matsuzaki, H; Michioka, T; Narimatsu, A; Numa, F; Yakabe, A; Yamashita, S | 1 |
Manno, T; Nakamura, Y; Suzuki, M; Ubukata, Y; Yamada, H; Yoshida, K; Yoshimura, Y | 1 |
Anserini, P; De Cecco, L; Lanera, P; Remorgida, V; Venturini, PL | 1 |
Abyholm, T; Henriksen, T; Magnus, O; Tanbo, T | 1 |
Buckler, HM; Burger, HG; Healy, DL; Kovacs, GT; Phillips, SE | 1 |
Abyholm, T; Dale, PO; Haug, E; Tanbo, T | 1 |
Shaw, RW | 1 |
Bahari, C; Blankstein, J; Kokia, E; Lunenfeld, B; Pariente, C; Shadmi, AL | 1 |
Camus, M; Deschacht, J; Devroey, P; Smitz, J; Van Steirteghem, AC; Van Waesberghe, L; Wisanto, A | 1 |
Coutts, JR; Fleming, R; Haxton, MJ | 1 |
Burger, HG; Healy, DL; McLachlan, RI | 1 |
Franssen, AM; Rolland, R; Vemer, HM; Willemsen, WN | 1 |
Burger, CW; Hompes, PG; Schoemaker, J; van Weissenbruch, MM | 1 |
Fleming, R | 1 |
Armitage, M; Dewbury, K; Wilkin, T | 1 |
Apa, R; Caruso, A; Fulghesu, AM; Lanzone, A; Mancuso, S; Menini, E; Spina, MA | 1 |
Buckler, HM; Burger, HG; Healy, DL; MacLachlan, VB; McLachlan, RI | 1 |
Alvarez, S; Antoine, JM; Cornet, D; Junca, AM; Mandelbaum, J; Plachot, M; Salat-Baroux, J; Tibi, C | 1 |
Franks, S; Kiddy, D; Mason, HD; Sagle, M | 1 |
Black, WP; Conaghan, CJ; Coutts, JR; Fleming, R; Hamilton, MP; Haxton, MJ; Yates, RW | 1 |
Faure, N; Lemay, A | 2 |
Iizuka, R; Nakamura, Y; Suzuki, M; Tamaoka, Y; Ubukata, Y; Yamada, H; Yoshida, K; Yoshimura, Y | 1 |
Adams, J; Brook, CG; Stanhope, R | 1 |
Black, WP; Coutts, JR; Fleming, R | 1 |
7 review(s) available for buserelin and Polycystic Ovarian Syndrome
Article | Year |
---|---|
Advances in induction of ovulation.
Topics: Buserelin; Clinical Trials as Topic; Clomiphene; Drug Administration Schedule; Drug Resistance; Female; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Gonadotropins; Growth Hormone; Humans; Hypogonadism; Naltrexone; Ovarian Hyperstimulation Syndrome; Ovulation Induction; Polycystic Ovary Syndrome; Pregnancy; Pregnancy Outcome | 1994 |
Treatment of polycystic ovary patients undergoing IVF.
Topics: Abortion, Spontaneous; Albumins; Antineoplastic Agents, Hormonal; Buserelin; Estradiol; Female; Fertilization in Vitro; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Growth Hormone; Humans; Luteinizing Hormone; Menotropins; Oocytes; Ovarian Hyperstimulation Syndrome; Polycystic Ovary Syndrome; Pregnancy | 1997 |
Use of luteinizing hormone releasing hormone agonists in polycystic ovary syndrome.
Topics: Abortion, Habitual; Buserelin; Female; Gonadotropin-Releasing Hormone; Humans; Infertility, Female; Ovarian Hyperstimulation Syndrome; Ovulation Induction; Polycystic Ovary Syndrome; Pregnancy | 1998 |
Severe ovarian hyperstimulation: a case report and essentials of prevention and management.
Topics: Adult; Buserelin; Female; Humans; Menotropins; Ovarian Hyperstimulation Syndrome; Ovulation Induction; Polycystic Ovary Syndrome | 1992 |
Goserelin. A review of its pharmacodynamic and pharmacokinetic properties, and clinical use in sex hormone-related conditions.
Topics: Animals; Breast Neoplasms; Buserelin; Drug Evaluation; Endometriosis; Female; Gonadal Steroid Hormones; Gonadotropin-Releasing Hormone; Gonadotropins; Goserelin; Humans; Leiomyoma; Male; Menstruation Disturbances; Polycystic Ovary Syndrome; Prostatic Neoplasms; Uterine Neoplasms | 1991 |
Clinical aspects of LHRH analogues in gynaecology: a review.
Topics: Adolescent; Adult; Breast Neoplasms; Buserelin; Clinical Trials as Topic; Contraceptive Agents, Female; Endometriosis; Female; Gonadotropin-Releasing Hormone; Hormones; Humans; Hypogonadism; Infertility, Female; Leiomyoma; Menstruation Disturbances; Pituitary Gland; Polycystic Ovary Syndrome; Uterine Neoplasms | 1986 |
The effects of buserelin on the hormonal states in PCOD.
Topics: Adult; Androstenedione; Buserelin; Estradiol; Estrone; Female; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Humans; Hydrocortisone; Luteinizing Hormone; Ovulation Induction; Polycystic Ovary Syndrome; Testosterone | 1986 |
22 trial(s) available for buserelin and Polycystic Ovarian Syndrome
Article | Year |
---|---|
Comparison of GnRH antagonist with long GnRH agonist protocol after OCP pretreatment in PCOs patients.
Topics: Adult; Buserelin; Contraceptives, Oral, Combined; Drug Administration Schedule; Drug Therapy, Combination; Ethinyl Estradiol-Norgestrel Combination; Female; Fertility Agents, Female; Gonadotropin-Releasing Hormone; Hormone Antagonists; Humans; Infertility, Female; Menotropins; Ovarian Hyperstimulation Syndrome; Ovulation Induction; Polycystic Ovary Syndrome; Pregnancy; Pregnancy Rate; Young Adult | 2010 |
Comparison of gonadotropin-releasing hormone agonists and antagonists in assisted reproduction cycles of polycystic ovarian syndrome patients.
Topics: Adult; Buserelin; Chi-Square Distribution; Drug Administration Schedule; Female; Fertility Agents, Female; Gonadotropin-Releasing Hormone; Humans; Infertility; Ovulation Induction; Polycystic Ovary Syndrome; Pregnancy; Pregnancy Outcome; Sperm Injections, Intracytoplasmic; Surveys and Questionnaires | 2010 |
IVM is an alternative for patients with PCO after failed conventional IVF attempt.
Topics: Adult; Buserelin; Embryo Transfer; Female; Follicle Stimulating Hormone; Humans; In Vitro Oocyte Maturation Techniques; Infertility, Female; Oocytes; Polycystic Ovary Syndrome; Pregnancy; Sperm Injections, Intracytoplasmic | 2011 |
Hyperinsulinemia amplifies GnRH agonist stimulated ovarian steroid secretion in women with polycystic ovary syndrome.
Topics: Adolescent; Adult; Blood Glucose; Buserelin; Cross-Sectional Studies; Female; Fertility Agents, Female; Gonadal Steroid Hormones; Humans; Hyperinsulinism; Insulin; Ovary; Polycystic Ovary Syndrome; Receptors, LHRH | 2012 |
The effect of metformin on ovarian stimulation and in vitro fertilization in insulin-resistant women with polycystic ovary syndrome: an open-label randomized cross-over trial.
Topics: Adult; Buserelin; Cross-Over Studies; Female; Fertilization in Vitro; Follicle Stimulating Hormone; Humans; Infertility, Female; Insulin Resistance; Metformin; Ovarian Hyperstimulation Syndrome; Ovulation Induction; Polycystic Ovary Syndrome; Recombinant Proteins | 2003 |
Initial estradiol response predicts outcome of exogenous gonadotropins using a step-down dose regimen for induction of ovulation in polycystic ovary syndrome.
Topics: Buserelin; Chorionic Gonadotropin; Estradiol; Female; Follicle Stimulating Hormone; Humans; Infertility, Female; Menotropins; Ovulation Induction; Polycystic Ovary Syndrome; Prospective Studies | 1995 |
Efficacy of low-dose GnRH analogue (Buserelin) in the treatment of hirsutism.
Topics: Adolescent; Adult; Androstane-3,17-diol; Androstenedione; Buserelin; Estradiol; Female; Follicle Stimulating Hormone; Follow-Up Studies; Hirsutism; Humans; Luteinizing Hormone; Menstruation Disturbances; Polycystic Ovary Syndrome; Sex Hormone-Binding Globulin; Testosterone; Time Factors | 1995 |
[Efficacy and endocrinological analysis of combined buserelin-pure FSH-hCG therapy in patients with polycystic ovary syndrome].
Topics: Adult; Buserelin; Chorionic Gonadotropin; Drug Therapy, Combination; Female; Follicle Stimulating Hormone; Gonadal Steroid Hormones; Humans; Polycystic Ovary Syndrome; Pregnancy | 1994 |
The effects of gonadotrophin-releasing hormone agonist on follicular development in patients with polycystic ovary syndrome in an in-vitro fertilization and embryo transfer programme.
Topics: Adult; Buserelin; Chorionic Gonadotropin; Embryo Transfer; Estradiol; Female; Fertilization in Vitro; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Humans; Luteinizing Hormone; Menotropins; Ovarian Follicle; Polycystic Ovary Syndrome | 1994 |
Metformin effects on clinical features, endocrine and metabolic profiles, and insulin sensitivity in polycystic ovary syndrome: a randomized, double-blind, placebo-controlled 6-month trial, followed by open, long-term clinical evaluation.
Topics: 17-alpha-Hydroxyprogesterone; Adolescent; Adult; Blood Glucose; Buserelin; Cholesterol; Double-Blind Method; Endocrine Glands; Female; Glucose Clamp Technique; Glucose Tolerance Test; Gonadotropin-Releasing Hormone; Humans; Hypoglycemic Agents; Insulin Resistance; Menstruation Disturbances; Metformin; Polycystic Ovary Syndrome; Triglycerides | 2000 |
Diagnosis of polycystic ovary disease in obese women with a 24-hour hormone profile after buserelin stimulation.
Topics: Adolescent; Adult; Buserelin; Female; Fertility Agents, Female; Gonadal Steroid Hormones; Humans; Insulin Resistance; Obesity; Polycystic Ovary Syndrome; Sensitivity and Specificity | 2000 |
Coasting may reduce the severity of the ovarian hyperstimulation syndrome in patients with polycystic ovary syndrome.
Topics: Adult; Buserelin; Female; Fertility Agents, Female; Humans; Menotropins; Ovarian Hyperstimulation Syndrome; Polycystic Ovary Syndrome; Reproductive Techniques | 2000 |
The response of patients with polycystic ovarian disease to human menopausal gonadotropin therapy after ovarian electrocautery or a luteinizing hormone-releasing hormone agonist.
Topics: Administration, Intranasal; Adult; Buserelin; Electrocoagulation; Female; Gonadotropin-Releasing Hormone; Humans; Luteinizing Hormone; Menotropins; Ovary; Ovulation; Polycystic Ovary Syndrome; Pregnancy; Testosterone | 1992 |
Recurrent spontaneous abortion and polycystic ovarian disease: comparison of two regimens to induce ovulation.
Topics: Abortion, Habitual; Adult; Buserelin; Clomiphene; Depression, Chemical; Female; Follicle Stimulating Hormone; Humans; Ovulation Induction; Pituitary Gland; Polycystic Ovary Syndrome; Pregnancy; Randomized Controlled Trials as Topic | 1990 |
Hormonal changes in patients with polycystic ovarian disease after ovarian electrocautery or pituitary desensitization.
Topics: Buserelin; Electrocoagulation; Estradiol; Female; Follicle Stimulating Hormone; Hormones; Humans; Insulin; Iodine Radioisotopes; Luteinizing Hormone; Polycystic Ovary Syndrome; Testosterone | 1990 |
A study on follicle stimulation and ovulation induction in polycystic ovary syndrome (PCOS).
Topics: Bromocriptine; Buserelin; Clomiphene; Drug Therapy, Combination; Female; Gonadotropin-Releasing Hormone; Humans; Menotropins; Ovarian Diseases; Ovarian Follicle; Ovulation Induction; Polycystic Ovary Syndrome; Pregnancy | 1990 |
Induction of ovulation with pulsatile subcutaneous administration of human menopausal gonadotropin in patients with polycystic ovary syndrome.
Topics: Adult; Buserelin; Drug Therapy, Combination; Female; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Humans; Luteinizing Hormone; Menotropins; Ovarian Diseases; Ovulation Induction; Periodicity; Pituitary Gland; Polycystic Ovary Syndrome; Pregnancy | 1990 |
Clinical aspects of LHRH analogues in gynaecology: a review.
Topics: Adolescent; Adult; Breast Neoplasms; Buserelin; Clinical Trials as Topic; Contraceptive Agents, Female; Endometriosis; Female; Gonadotropin-Releasing Hormone; Hormones; Humans; Hypogonadism; Infertility, Female; Leiomyoma; Menstruation Disturbances; Pituitary Gland; Polycystic Ovary Syndrome; Uterine Neoplasms | 1986 |
The additional use of buserelin in HMG-HCG ovulation induction in PCO: a double blind controlled study.
Topics: Buserelin; Chorionic Gonadotropin; Clinical Trials as Topic; Double-Blind Method; Estrogens; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Menotropins; Ovulation Induction; Polycystic Ovary Syndrome | 1986 |
Comparison between long and short protocols of LHRH agonist in the treatment of polycystic ovary disease by in-vitro fertilization.
Topics: Adult; Androgens; Buserelin; Estradiol; Female; Fertilization in Vitro; Humans; Infertility, Female; Polycystic Ovary Syndrome; Pregnancy; Progesterone | 1988 |
Use of LHRH agonists in the treatment of anovulation in women with polycystic ovary syndrome.
Topics: Anovulation; Buserelin; Clinical Trials as Topic; Drug Therapy, Combination; Female; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Humans; Luteinizing Hormone; Menotropins; Ovulation; Polycystic Ovary Syndrome; Pregnancy | 1987 |
Treatment of polycystic ovarian disease by inducing ovulation with pulsatile subcutaneous administration of human menopausal gonadotrophin associated with luteinizing hormone-releasing hormone analogue.
Topics: Adult; Buserelin; Clinical Trials as Topic; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Infusion Pumps; Menotropins; Ovulation Induction; Polycystic Ovary Syndrome | 1988 |
59 other study(ies) available for buserelin and Polycystic Ovarian Syndrome
Article | Year |
---|---|
Failure of triggering oocyte maturation with a GnRH agonist in polycystic ovary syndrome: two case reports.
Topics: Adult; Buserelin; Chorionic Gonadotropin; Embryo Transfer; Female; Fertilization in Vitro; Gonadotropin-Releasing Hormone; Humans; Oocytes; Oogenesis; Ovarian Hyperstimulation Syndrome; Polycystic Ovary Syndrome; Treatment Failure | 2011 |
Basal insulin-like factor 3 levels predict functional ovarian hyperandrogenism in the polycystic ovary syndrome.
Topics: 17-alpha-Hydroxyprogesterone; Adolescent; Adult; Body Mass Index; Buserelin; Female; Fertility Agents, Female; Gonadotropin-Releasing Hormone; Humans; Hyperandrogenism; Insulin; Luteinizing Hormone; Middle Aged; Ovary; Polycystic Ovary Syndrome; Proteins; Young Adult | 2011 |
Effect of pituitary down-regulation on the ovary before in vitro fertilization as measured using three-dimensional power Doppler ultrasound.
Topics: Buserelin; Down-Regulation; Female; Fertilization in Vitro; Humans; Imaging, Three-Dimensional; Ovary; Pituitary Gland; Polycystic Ovary Syndrome; Prospective Studies; Ultrasonography, Doppler | 2003 |
Prevalence of polycystic ovarian changes and polycystic ovary syndrome in premenopausal women with treated type 2 diabetes mellitus.
Topics: Adult; Buserelin; Case-Control Studies; Diabetes Mellitus, Type 2; Female; Follicle Stimulating Hormone; Hirsutism; Humans; Luteinizing Hormone; Ovary; Polycystic Ovary Syndrome; Premenopause; Prevalence; Sex Hormone-Binding Globulin; Ultrasonography | 2006 |
17-hydroxyprogesterone responses to gonadotropin-releasing hormone disclose distinct phenotypes of functional ovarian hyperandrogenism and polycystic ovary syndrome.
Topics: 17-alpha-Hydroxyprogesterone; Adolescent; Adult; Anthropometry; Blood Glucose; Buserelin; C-Peptide; Cosyntropin; Dexamethasone; Female; Glucose Tolerance Test; Gonadotropin-Releasing Hormone; Hormones; Humans; Hyperandrogenism; Insulin; Middle Aged; Ovarian Diseases; Phenotype; Polycystic Ovary Syndrome; Prospective Studies | 2007 |
Comparison of oocyte quality and intracytoplasmic sperm injection outcome in women with isolated polycystic ovaries or polycystic ovarian syndrome.
Topics: Abortion, Spontaneous; Adult; Buserelin; Case-Control Studies; Embryo Transfer; Estradiol; Female; Fertility Agents, Female; Humans; Male; Oocyte Retrieval; Oocytes; Polycystic Ovary Syndrome; Pregnancy; Pregnancy Rate; Retrospective Studies; Sperm Injections, Intracytoplasmic | 2008 |
Gonadotrophin and gonadal steroid response to a single dose of a long-acting agonist of gonadotrophin-releasing hormone in ovulatory and anovulatory women with polycystic ovary syndrome.
Topics: 17-alpha-Hydroxyprogesterone; Adrenal Glands; Adrenocorticotropic Hormone; Adult; Androstenedione; Anovulation; Buserelin; Dexamethasone; Female; Gonadal Steroid Hormones; Gonadotropins, Pituitary; Humans; Hydroxyprogesterones; Luteinizing Hormone; Ovary; Pituitary Gland; Polycystic Ovary Syndrome; Testosterone | 1995 |
Gonadotropin-releasing hormone agonist versus human chorionic gonadotropin as a trigger of ovulation in polycystic ovarian disease gonadotropin hyperstimulated cycles.
Topics: Adult; Buserelin; Chorionic Gonadotropin; Estradiol; Female; Humans; Ovarian Hyperstimulation Syndrome; Ovulation Induction; Polycystic Ovary Syndrome; Progesterone; Prospective Studies | 1994 |
Luteal function following ovulation induction in polycystic ovary syndrome patients using exogenous gonadotrophins in combination with a gonadotrophin-releasing hormone agonist.
Topics: Adult; Buserelin; Chorionic Gonadotropin; Drug Therapy, Combination; Female; Follicle Stimulating Hormone; Gonadotropins; Humans; Luteal Phase; Luteinizing Hormone; Menotropins; Ovulation Induction; Polycystic Ovary Syndrome; Reference Values | 1993 |
Pulsatile gonadotrophin releasing hormone stimulation after medium-term pituitary suppression in polycystic ovary syndrome.
Topics: Adult; Buserelin; Female; Follicular Phase; Gonadotropin-Releasing Hormone; Humans; Luteinizing Hormone; Ovarian Follicle; Ovary; Ovulation Induction; Periodicity; Polycystic Ovary Syndrome; Pregnancy; Ultrasonography | 1993 |
The effects of a gonadotrophin-releasing hormone agonist on treatment with low dose follicle stimulating hormone in polycystic ovary syndrome.
Topics: Adult; Buserelin; Chorionic Gonadotropin; Combined Modality Therapy; Estrogens; Female; Follicle Stimulating Hormone; Humans; Ovarian Follicle; Ovulation; Polycystic Ovary Syndrome; Pregnancy | 1993 |
Evaluation of ovarian and adrenal sources of androgens in women with polycystic ovary syndrome. Dexamethasone and GnRH-agonist administration.
Topics: Adrenal Glands; Adult; Androgens; Buserelin; Dexamethasone; Female; Humans; Ovary; Polycystic Ovary Syndrome; Time Factors | 1993 |
Miscarriage rates following in-vitro fertilization are increased in women with polycystic ovaries and reduced by pituitary desensitization with buserelin.
Topics: Abortion, Spontaneous; Adult; Buserelin; Clomiphene; Female; Fertilization in Vitro; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Menotropins; Pituitary Gland; Polycystic Ovary Syndrome; Pregnancy; Prevalence; Reference Values; Retrospective Studies | 1993 |
17-Hydroxyprogesterone response to buserelin testing in the polycystic ovary syndrome.
Topics: 17-alpha-Hydroxyprogesterone; Adolescent; Adrenocorticotropic Hormone; Adult; Buserelin; Dexamethasone; Female; Follicle Stimulating Hormone; Humans; Hydroxyprogesterones; Luteinizing Hormone; Ovary; Polycystic Ovary Syndrome; Testosterone | 1993 |
The relationship between follicle-stimulating hormone dose and level and its relevance for ovulation induction with adjuvant gonadotropin-releasing hormone-agonist treatment.
Topics: Adjuvants, Pharmaceutic; Adult; Buserelin; Differential Threshold; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Mathematics; Ovarian Follicle; Ovulation Detection; Polycystic Ovary Syndrome | 1993 |
Serum FSH bioactivity and response to acute gonadotrophin releasing hormone (GnRH) agonist stimulation in patients with polycystic ovary syndrome (PCOS) as compared to control groups.
Topics: Adolescent; Adult; Animals; Biological Assay; Buserelin; Female; Follicle Stimulating Hormone; Follicular Phase; Hirsutism; Humans; Male; Polycystic Ovary Syndrome; Rats; Stimulation, Chemical | 1993 |
Assisted conception using buserelin and human menopausal gonadotrophins in women with polycystic ovary syndrome.
Topics: Adult; Buserelin; Chorionic Gonadotropin; Estradiol; Female; Fertilization in Vitro; Gamete Intrafallopian Transfer; Humans; Infertility, Female; Ovarian Hyperstimulation Syndrome; Polycystic Ovary Syndrome; Pregnancy; Pregnancy Outcome; Risk Factors | 1993 |
The prognostic value of basal luteinizing hormone:follicle-stimulating hormone ratio in the treatment of patients with polycystic ovarian syndrome by assisted reproduction techniques.
Topics: Abortion, Spontaneous; Buserelin; Female; Follicle Stimulating Hormone; Follicular Phase; Humans; Infertility, Female; Luteinizing Hormone; Menotropins; Ovarian Follicle; Polycystic Ovary Syndrome; Pregnancy; Prognosis; Reproductive Techniques; Retrospective Studies | 1995 |
Induction of multifollicular growth in patients non responding to clomiphene citrate and gonadotropins or gonadotropins only.
Topics: Adult; Anovulation; Buserelin; Chorionic Gonadotropin; Clomiphene; Estradiol; Female; Follicle Stimulating Hormone; Humans; Hypothalamic Diseases; Luteinizing Hormone; Ovarian Follicle; Polycystic Ovary Syndrome; Ultrasonography | 1995 |
The effect of sequential administration of octreotide alone and octreotide/growth hormone simultaneously on buserelin stimulated ovarian steroid secretion in women with polycystic ovary syndrome.
Topics: Adolescent; Adult; Androstenedione; Buserelin; Drug Administration Schedule; Drug Therapy, Combination; Estradiol; Female; Glucose Tolerance Test; Hormones; Human Growth Hormone; Humans; Insulin; Insulin-Like Growth Factor I; Luteinizing Hormone; Male; Octreotide; Polycystic Ovary Syndrome; Testosterone | 1996 |
Lack of relationship between 17-hydroxyprogesterone response to buserelin testing and hyperinsulinemia in polycystic ovary syndrome.
Topics: 17-alpha-Hydroxyprogesterone; Adolescent; Adult; Buserelin; C-Peptide; Female; Follicle Stimulating Hormone; Glucose; Glucose Tolerance Test; Gonadotropin-Releasing Hormone; Humans; Hyperinsulinism; Insulin; Luteinizing Hormone; Polycystic Ovary Syndrome; Prolactin; Steroid 17-alpha-Hydroxylase; Testosterone; Time Factors | 1997 |
Serum FSH levels in women with polycystic ovary syndrome during ovulation induction using down-regulation and urofollitropin.
Topics: Adult; Buserelin; Embryo Transfer; Female; Fertilization in Vitro; Follicle Stimulating Hormone; Humans; Infertility, Female; Obesity; Ovulation; Ovulation Induction; Polycystic Ovary Syndrome; Pregnancy; Pregnancy Rate; Retrospective Studies | 1997 |
17-Hydroxyprogesterone responses to gonadotrophin-releasing hormone agonist buserelin and adrenocorticotrophin in polycystic ovary syndrome: investigation of adrenal and ovarian cytochrome P450c17alpha dysregulation.
Topics: 17-alpha-Hydroxyprogesterone; Adolescent; Adrenal Glands; Adrenocorticotropic Hormone; Adult; Androgens; Buserelin; Cytochrome P-450 Enzyme System; Female; Humans; Injections, Intravenous; Ovary; Polycystic Ovary Syndrome; Reference Values; Steroid 17-alpha-Hydroxylase | 1997 |
The pattern of changes in ovarian stromal and uterine artery blood flow velocities during in vitro fertilization treatment and its relationship with outcome of the cycle.
Topics: Adult; Blood Flow Velocity; Buserelin; Chorionic Gonadotropin; Endosonography; Female; Fertilization in Vitro; Follicular Phase; Follow-Up Studies; Humans; Iliac Artery; Infertility, Female; Ovary; Polycystic Ovary Syndrome; Pregnancy; Prospective Studies; Pulsatile Flow; Treatment Outcome; Ultrasonography, Doppler, Color; Uterus; Vagina | 1999 |
Relationship of ovarian stromal volume and serum 17-hydroxyprogesterone concentrations in patients with PCOS.
Topics: 17-alpha-Hydroxyprogesterone; Biomarkers; Buserelin; Female; Fertility Agents, Female; Gonadotropin-Releasing Hormone; Humans; Ovary; Polycystic Ovary Syndrome | 1999 |
The effects of metformin on insulin resistance and ovarian steroidogenesis in women with polycystic ovary syndrome.
Topics: 17-alpha-Hydroxyprogesterone; Adult; Androstenedione; Buserelin; Case-Control Studies; Female; Follicle Stimulating Hormone; Glucose Tolerance Test; Humans; Hyperinsulinism; Hypoglycemic Agents; Insulin Resistance; Luteinizing Hormone; Metformin; Polycystic Ovary Syndrome; Statistics, Nonparametric | 1999 |
Limited ovarian stimulation (LOS), prevents the recurrence of severe forms of ovarian hyperstimulation syndrome in polycystic ovarian disease.
Topics: Administration, Intranasal; Adult; Buserelin; Cell Count; Chorionic Gonadotropin; Embryo Transfer; Estradiol; Female; Fertilization in Vitro; Humans; Infertility, Female; Oocytes; Ovarian Hyperstimulation Syndrome; Ovulation Induction; Polycystic Ovary Syndrome; Pregnancy; Prospective Studies; Recurrence; Specimen Handling; Time Factors | 2001 |
The impact of obesity and insulin resistance on the outcome of IVF or ICSI in women with polycystic ovarian syndrome.
Topics: Androstenedione; Buserelin; Drug Resistance; Estradiol; Female; Fertilization in Vitro; Follicle Stimulating Hormone; Humans; Insulin; Insulin Resistance; Luteinizing Hormone; Obesity; Ovulation Induction; Polycystic Ovary Syndrome; Pregnancy; Recombinant Proteins; Sex Hormone-Binding Globulin; Sperm Injections, Intracytoplasmic; Testosterone; Treatment Outcome | 2001 |
Mechanisms involved in the pituitary desensitization induced by gonadotropin-releasing hormone agonists.
Topics: Animals; Buserelin; Cells, Cultured; Endometriosis; Female; Gonadotropin-Releasing Hormone; Humans; Infertility, Female; Leuprolide; Luteinizing Hormone; Male; Nafarelin; Pituitary Gland; Polycystic Ovary Syndrome; Rats; Rats, Sprague-Dawley; Rats, Wistar; Receptors, LHRH; RNA, Messenger | 1992 |
Ovulation induction with human menopausal gonadotropin versus follicle-stimulating hormone after pituitary suppression by gonadotropin releasing hormone agonist in polycystic ovary disease. A cross-over study.
Topics: Adult; Analysis of Variance; Androstenedione; Anovulation; Biological Assay; Buserelin; Estradiol; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Menotropins; Ovary; Ovulation Induction; Pituitary Gland; Polycystic Ovary Syndrome; Radioimmunoassay; Testosterone | 1992 |
Persistence of hyperinsulinemia in polycystic ovary syndrome after ovarian suppression by gonadotropin-releasing hormone agonist.
Topics: Adult; Androstenedione; Blood Glucose; Buserelin; Female; Glucose Tolerance Test; Humans; Insulin; Luteinizing Hormone; Polycystic Ovary Syndrome; Testosterone | 1992 |
Growth patterns of ovarian follicles during induction of ovulation with decreasing doses of human menopausal gonadotropin following presumed selection in polycystic ovary syndrome.
Topics: Adult; Buserelin; Drug Administration Schedule; Female; Follicle Stimulating Hormone; Humans; Infertility, Female; Menotropins; Ovarian Follicle; Ovulation Induction; Polycystic Ovary Syndrome; Random Allocation; Ultrasonography | 1992 |
In-vitro fertilization in infertile women with the polycystic ovarian syndrome.
Topics: Buserelin; Female; Fertilization in Vitro; Humans; Infertility, Female; Ovulation Induction; Polycystic Ovary Syndrome | 1991 |
Triggering ovulation with endogenous luteinizing hormone may prevent the ovarian hyperstimulation syndrome.
Topics: Administration, Intranasal; Anovulation; Buserelin; Chorionic Gonadotropin; Estradiol; Female; Humans; Infertility, Female; Luteinizing Hormone; Ovulation; Polycystic Ovary Syndrome; Progesterone; Superovulation | 1991 |
Inhibitory effect of sandostatin on secretion of luteinising hormone and ovarian steroids in polycystic ovary syndrome.
Topics: Adolescent; Adult; Androgen Antagonists; Buserelin; Drug Administration Schedule; Estradiol; Female; Follicle Stimulating Hormone; Gonadotropins; Humans; Injections, Subcutaneous; Luteinizing Hormone; Octreotide; Ovary; Polycystic Ovary Syndrome; Testosterone | 1990 |
Insulin secretion in polycystic ovarian disease: effect of ovarian suppression by GnRH agonist.
Topics: Adult; Buserelin; Fasting; Female; Glucose Tolerance Test; Gonadal Steroid Hormones; Humans; Insulin; Insulin Secretion; Obesity; Ovary; Pituitary Hormone-Releasing Hormones; Polycystic Ovary Syndrome | 1990 |
Ovarian sensitivity to gonadotrophins in patients with PCO is unaffected by suppression of LH.
Topics: Buserelin; Chorionic Gonadotropin; Depression, Chemical; Female; Humans; Luteinizing Hormone; Menotropins; Ovarian Follicle; Ovary; Polycystic Ovary Syndrome | 1990 |
Stimulation with human menopausal gonadotropin versus follicle-stimulating hormone after pituitary suppression in polycystic ovarian syndrome.
Topics: Adult; Buserelin; Embryo Transfer; Female; Fertilization in Vitro; Follicle Stimulating Hormone; Gonadal Steroid Hormones; Humans; Menotropins; Ovarian Diseases; Pituitary Gland; Polycystic Ovary Syndrome; Pregnancy | 1990 |
Growth hormone and somatomedin-C secretion in patients with polycystic ovarian disease. Their relationships with hyperinsulinism and hyperandrogenism.
Topics: Adult; Androstenedione; Buserelin; Estradiol; Female; Glucose; Growth Hormone; Humans; Hyperinsulinism; Obesity; Polycystic Ovary Syndrome; Somatomedins; Testosterone | 1990 |
LH pulsatility and response to a single s.c. injection of buserelin in polycystic ovary syndrome.
Topics: Adult; Amenorrhea; Blood Glucose; Buserelin; C-Peptide; Female; Gonadal Steroid Hormones; Humans; Insulin; Luteinizing Hormone; Oligomenorrhea; Polycystic Ovary Syndrome; Pulsatile Flow | 1990 |
Failure to improve ovarian response by combined gonadotropin-releasing hormone agonist and gonadotropin therapy.
Topics: Adult; Buserelin; Down-Regulation; Drug Therapy, Combination; Estradiol; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Menotropins; Oligomenorrhea; Ovary; Ovulation Induction; Pituitary Gland; Polycystic Ovary Syndrome | 1990 |
Effect of long-term inhibition of gonadotrophin secretion by the gonadotrophin-releasing hormone agonist, buserelin, on sex steroid secretion and ovarian morphology in polycystic ovary syndrome.
Topics: Adult; Androstenedione; Buserelin; Depression, Chemical; Female; Follicle Stimulating Hormone; Gonadal Steroid Hormones; Humans; Hypothalamus; Luteinizing Hormone; Ovary; Ovulation; Pituitary Gland; Polycystic Ovary Syndrome; Testosterone | 1990 |
Administration of pure follicle-stimulating hormone during gonadotropin-releasing hormone agonist therapy in patients with clomiphene-resistant polycystic ovarian disease: hormonal evaluations and clinical perspectives.
Topics: Adult; Buserelin; Clomiphene; Estradiol; Female; Follicle Stimulating Hormone; Humans; Ovulation Induction; Polycystic Ovary Syndrome; Pregnancy | 1989 |
Gonadotropin and ovarian steroid production in polycystic ovarian syndrome during suppression with a gonadotropin-releasing hormone agonist.
Topics: Administration, Intranasal; Adult; Androgens; Buserelin; Estrogens; Female; Gonadotropins, Pituitary; Humans; Ovary; Polycystic Ovary Syndrome | 1989 |
GnRH agonist administration in polycystic ovary syndrome.
Topics: Administration, Intranasal; Adult; Buserelin; Female; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Gonadotropins; Humans; Inhibins; Injections, Intramuscular; Luteinizing Hormone; Menotropins; Ovary; Ovulation; Pituitary Gland; Polycystic Ovary Syndrome; Radioimmunoassay; Steroids | 1989 |
GnRH-agonist therapy in women with the polycystic ovarian syndrome: effects on ovarian volume and on gonadotropin and sex steroid levels.
Topics: Administration, Intranasal; Androgens; Buserelin; Estradiol; Female; Follicle Stimulating Hormone; Humans; Infertility, Female; Luteinizing Hormone; Ovary; Polycystic Ovary Syndrome | 1989 |
GnRH agonists-antagonists--clinical applications.
Topics: Buserelin; Danazol; Endometriosis; Estradiol; Female; Gonadotropin-Releasing Hormone; Goserelin; Humans; Leiomyoma; Nafarelin; Osteolysis; Polycystic Ovary Syndrome; Uterine Neoplasms | 1988 |
Abolishment of the positive feedback mechanism: a criterion for temporary medical hypophysectomy by LH-RH agonist.
Topics: Administration, Intranasal; Buserelin; Drug Administration Schedule; Female; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Humans; Hypophysectomy; Hypophysectomy, Chemical; Infertility, Female; Injections, Subcutaneous; Luteinizing Hormone; Luteolytic Agents; Polycystic Ovary Syndrome; Triptorelin Pamoate | 1987 |
Inhibition of gonadotropic and ovarian function by intranasal administration of D-Ser (TBU)6-EA10-LHRH in normo-ovulatory women and patients with polycystic ovary disease.
Topics: Administration, Intranasal; Buserelin; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Estradiol; Estrogens; Female; Follicle Stimulating Hormone; Gonadotropins; Humans; Luteinizing Hormone; Ovary; Polycystic Ovary Syndrome | 1988 |
Population study of causes, treatment, and outcome of infertility.
Topics: Buserelin; Female; Humans; Infertility, Female; Menotropins; Ovulation Induction; Polycystic Ovary Syndrome; Pregnancy | 1986 |
Induction of ovulation in polycystic ovarian disease.
Topics: Buserelin; Chorionic Gonadotropin; Drug Therapy, Combination; Estradiol; Female; Humans; Infertility, Female; Luteinizing Hormone; Menotropins; Ovulation Induction; Polycystic Ovary Syndrome; Pregnancy; Progesterone | 1986 |
Successful treatment of infertility due to polycystic ovary disease using a combination of luteinising hormone releasing hormone agonist and low dosage menotrophin.
Topics: Adult; Buserelin; Chorionic Gonadotropin; Drug Therapy, Combination; Estradiol; Female; Follicle Stimulating Hormone; Humans; Infertility, Female; Luteinizing Hormone; Menotropins; Polycystic Ovary Syndrome | 1987 |
Successful induction of ovulation and conception with combined gonadotropin-releasing hormone agonist plus highly purified follicle-stimulating hormone in patients with polycystic ovarian disease.
Topics: Adult; Buserelin; Drug Combinations; Drug Therapy, Combination; Estradiol; Female; Fertilization; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Ovary; Ovulation; Ovulation Induction; Polycystic Ovary Syndrome; Pregnancy | 1987 |
Serum inhibin levels in polycystic ovary syndrome: basal levels and response to luteinizing hormone-releasing hormone agonist and exogenous gonadotropin administration.
Topics: Adult; Buserelin; Estradiol; Female; Follicle Stimulating Hormone; Gonadotropins; Humans; Inhibins; Luteinizing Hormone; Ovulation Induction; Polycystic Ovary Syndrome; Reference Values | 1988 |
Combined gonadotropin-releasing hormone analog and exogenous gonadotropins for ovulation induction in infertile women: efficacy related to ovarian function assessment.
Topics: Adult; Buserelin; Chorionic Gonadotropin; Drug Therapy, Combination; Female; Humans; Infertility, Female; Luteal Phase; Luteinizing Hormone; Menotropins; Menstrual Cycle; Oligomenorrhea; Ovulation Induction; Polycystic Ovary Syndrome; Progesterone | 1988 |
Ovarian suppression in polycystic ovarian disease during 6 month administration of a luteinizing hormone-releasing hormone (LH-RH) agonist.
Topics: 17-alpha-Hydroxyprogesterone; Adolescent; Adult; Androgens; Buserelin; Estradiol; Female; Gonadotropins, Pituitary; Humans; Hydroxyprogesterones; Polycystic Ovary Syndrome; Time Factors | 1987 |
Acute pituitary-ovarian response during chronic luteinizing hormone-releasing hormone agonist administration in polycystic ovarian syndrome.
Topics: Buserelin; Estradiol; Female; Gonadotropins, Pituitary; Humans; Ovary; Pituitary Gland; Polycystic Ovary Syndrome; Testosterone | 1988 |
The treatment of central precocious puberty using an intranasal LHRH analogue (buserelin).
Topics: Administration, Intranasal; Buserelin; Child; Child, Preschool; Female; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Humans; Luteinizing Hormone; Male; Polycystic Ovary Syndrome; Puberty, Precocious | 1985 |
Effects of LH suppression in polycystic ovary syndrome.
Topics: Adult; Androstenedione; Buserelin; Depression, Chemical; Estradiol; Estrone; Female; Humans; Luteinizing Hormone; Ovary; Polycystic Ovary Syndrome; Testosterone | 1985 |